Alexandra Kropotova

Alexandra Kropotova

Chief Tech/Sci/R&D Officer at SAB BIOTHERAPEUTICS, INC.

Net worth: 1 697 $ as of 2024-03-30

51 year
Health Technology
Consumer Services

Profile

Alexandra Kropotova is an Independent Director at iBio, Inc. and the Chief Medical Officer & Executive Vice President at SAB Biotherapeutics, Inc. She previously worked as the Director & Head-Global Clinical Respiratory at Pfizer Inc. from 2002 to 2007, and as the Vice President-Strategy at Sanofi SA from 2007 to 2016.
She also held the position of VP-Global Specialty Research & Development at Teva Pharmaceuticals, Inc. Dr. Kropotova holds an MBA degree from Ohio University Graduate College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-10-24 418 ( 0.00% ) 1 697 $ 2024-03-30
2024-03-17 0 ( -.--% ) - $ 2024-03-30

Alexandra Kropotova active positions

CompaniesPositionStart
IBIO, INC. Director/Board Member 2020-10-13
SAB BIOTHERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2022-06-05
All active positions of Alexandra Kropotova

Former positions of Alexandra Kropotova

CompaniesPositionEnd
Sanofi SA Corporate Officer/Principal 2015-12-31
PFIZER, INC. Director/Board Member 2006-12-31
Corporate Officer/Principal -
See the detail of Alexandra Kropotova's experience

Training of Alexandra Kropotova

Ohio University Graduate College Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Alexandra Kropotova's experience

Connections

100 +

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
PFIZER, INC.

Health Technology

IBIO, INC.

Health Technology

SAB BIOTHERAPEUTICS, INC.

Health Technology

Private companies2
Sanofi SA

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Alexandra Kropotova